Clinical Trial: Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Patients Under the "New-Drug Re-examination

Brief Summary: The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.